Did CDC Officials Mislead The Public About COVID Vaccine Efficacy? Rep. Massie Says “Yes”


Via American Greatness, When Congressman Thomas Massie (R-KY) contacted officials from the Centers for Disease Control and Prevention (CDC) in December of 2020, he wanted to know if taking the…[...]

Three years on, COVID-19 and the skin: long-term impacts, emerging trends and clinical practice 


Esther E Freeman, Ignacio Garcia-Doval, Luigi Naldi, Roderick J Hay British Journal of Dermatology, Volume 189, Issue 1, July 2023, Pages 1–, https://doi.org/10.1093/bjd/ljad131 In early 2020 there were reports of a new and potentially fatal…[...]

DERMATOLOGIC MANIFESTATIONS OF COVID-19 CAN BECOME “LONG-HAULER” SYMPTOMS


Originally published on The Lancet Infectious Disease KEY FINDINGS Using an international registry, researchers at Massachusetts General Hospital evaluated the duration of dermatological signs and symptoms of COVID-19 in 234 patients,…[...]

Two-Year Longitudinal Study Reveals That Long COVID Symptoms Peak and Quality of Life Nadirs at 6–12 Months Postinfection 


Zoe O Demko, Tong Yu, Sarika K Mullapudi, M Gabriela Varela Heslin, et. al. Open Forum Infectious Diseases, Volume 11, Issue 3, March 2024, ofae027, https://doi.org/10.1093/ofid/ofae027 Abstract Background Few longitudinal studies available characterize long COVID…[...]

Role of MicroRNA-21 in Regulating Intracellular Pathways Associated With Phagocytosis in Human Macrophages: An In Vitro Study


Natsuki Anada • Yoshinobu Nakayama • Jun Takeshita • Kyoko Kageyama • Hiroatsu Sakamoto • Takahiko Kamibayashi • Yasufumi Nakajima 2024, DOI: 10.7759/cureus.63736  Abstract Introduction The efficient clearance of bacteria by macrophages is crucial for the timely resolution of inflammation. In this study,…[...]

IL-13 decreases susceptibility to airway epithelial SARS-CoV-2 infection but increases disease severity in vivo


Shreya Ghimire, Biyun Xue, Kun Li, Ryan M Gannon, et. al.doi: https://doi.org/10.1101/2024.07.03.60194 Abstract Treatments available to prevent progression of virus-induced lung diseases, including coronavirus disease 2019 (COVID-19) are of limited benefit once respiratory failure occurs. The efficacy of approved…[...]

Spatial transcriptomics unveils the in situ cellular and molecular hallmarks of the lung in fatal COVID-19


Carlos Garcia-Prieto, Eva Musulen, Veronica Davalos,  et. al.doi: https://doi.org/10.1101/2024.07.03.601404 00010010 Abstract Severe Coronavirus disease 2019 (COVID-19) induces heterogeneous and progressive diffuse alveolar damage (DAD) highly disrupting lung tissue architecture and homeostasis, hampering disease management and leading to…[...]

‘Visionary’ study finds inflammation, evidence of Covid virus years after infection


By Isabella Cueto, 2024 Stat Reporting Remember when we thought Covid was a two-week illness? So does Michael Peluso, assistant professor of medicine at the University of California, San Francisco.  He recalls…[...]

COVID-19 and spinal cord injury: clinical presentation, clinical course, and clinical outcomes of people hospitalised


Inge E. Eriks-Hoogland, Michael A. Barth, Lorena L. Müller, et. al. Spinal Cord Series and Cases volume 10, Article number: 5 (2024)  Abstract Study design Retrospective study Objectives To describe the presenting symptoms/signs, clinical course and outcomes in…[...]